DrugPatentWatch Database Preview
Alvogen Company Profile
What is the competitive landscape for ALVOGEN, and what generic alternatives to ALVOGEN drugs are available?
ALVOGEN has fifty-two approved drugs.
There is one US patent protecting ALVOGEN drugs.
There is one patent family member on ALVOGEN drugs in one country and one hundred and forty-five supplementary protection certificates in fourteen countries.
Summary for Alvogen
| International Patents: | 1 |
| US Patents: | 1 |
| Tradenames: | 47 |
| Ingredients: | 44 |
| NDAs: | 52 |
| Patent Litigation for Alvogen: | See patent lawsuits for Alvogen |
| PTAB Cases with Alvogen as petitioner: | See PTAB cases with Alvogen as petitioner |
Drugs and US Patents for Alvogen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 204403-003 | Aug 31, 2015 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Alvogen Inc | PRIMAQUINE PHOSPHATE | primaquine phosphate | TABLET;ORAL | 203924-001 | Feb 3, 2014 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Alvogen | FELBAMATE | felbamate | TABLET;ORAL | 204595-001 | Jan 11, 2016 | AB | RX | No | No | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alvogen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alvogen | ZESTORETIC | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019888-003 | Nov 18, 1993 | 4,374,829*PED | See Pricing |
| Alvogen | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-001 | Apr 21, 1993 | 4,892,741 | See Pricing |
| Alvogen | ZESTORETIC | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019888-001 | Sep 20, 1990 | 4,472,380 | See Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ALVOGEN drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 450 mg | ➤ Subscribe | 2013-02-28 |
International Patents for Alvogen Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2008038155 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alvogen Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2822954 | 1890030-8 | Sweden | See Pricing | PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM; REG. NO/DATE: EU/1/18/1289 20180625 |
| 1713823 | 1490064-1 | Sweden | See Pricing | PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516 |
| 0398460 | 12/2004 | Austria | See Pricing | PRODUCT NAME: DROSPIRENON IN KOMBINATION MIT ESTRADIOL; NAT. REGISTRATION NO/DATE: 1-25178, 1-25179 20031127; FIRST REGISTRATION: NL RVG 27505 20021211 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
